Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon.

• We have investigated the functional expression of mu-opioid receptors (MORs) in the human colon cancer cell line, HT-29. As revealed by immunocytochemistry, immunoreactivity was present in both the cytoplasm and nuclei of the cells. Challenge with morphine for 24 h (1 nM to 1 microM) barely affected cell proliferation, while the secretion of urokinase type plasminogen activator (a protease involved in invasion/metastasis) was markedly augmented by a concentration of 0.1 microM. Human colon cancer tissue from 14 consecutively operated patients was investigated by immunohistochemistry. MORs were found in the nuclei of colonocytes and immune cells of the lamina propria in tumor-free tissue. In tumor tissue, immunoreactivity was found in the membrane and often in the nuclei of tumor cells. The current findings suggest that morphine administration could affect tumor progression by interfering with, for example, invasive properties. Our demonstration of a nuclear expression of the MORs appears to be a novel finding.

Nyckelord

Cell Nucleus

metabolism

Cell Proliferation

Colon

metabolism

Colonic Neoplasms

drug therapy

metabolism

Disease Progression

HT29 Cells

Humans

Immunohistochemistry

Morphine

pharmacology

Narcotics

pharmacology

Neoplasm Invasiveness

Receptors

Opioid

mu

metabolism

Urinary Plasminogen Activator

metabolism

Biomedicinsk vetenskap

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)